跳至主要内容
临床试验/NCT02155764
NCT02155764已完成2 期

Comparison of Octacalcium Phosphate Synthetic Bone Graft (OctoFor) and Bovine-derived Bone (Bio-Oss) for Ridge Preservation After Tooth Extraction: Open, Prospective, Non-Randomised Clinical Trial

I.M. Sechenov First Moscow State Medical University2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2016年9月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
60
试验地点
2
主要终点
The changes of bone level between baseline and 3 months post-extraction at the time of implantation

研究概览

简要总结

Return to normal life and shortening rehabilitation period of patients after surgical removal of teeth is important and urgent social problem. In this regard, higher demands for quality of care and treatment of patients, which requires the development of new approaches to the treatment of patients, the introduction of new technologies and the associated development of new materials . Serious problem of contemporary oral and maxillo-facial surgery and dentistry is augmentation of bone defects generated during the surgical treatment of diseases and injuries of the bones. The results of surgical repair of bone defects are more dependent on the course of the process of reparative osteogenesis. Long-term periods of clinical studies indicate that reparative osteogenesis in posttraumatic bone defects is slow - months and years, and in some cases no bone defects filled with bone tissue.

This project aims at addressing the preservation of bone volume in humans after tooth extraction using biomaterials with optimum performance. The practical significance of the project is to establish an effective tissue response and, thus, possible subsequent quality installation of dental implants. The proposed solution is based on the scientific development of the operative techniques, and a comparative analysis of several classes of biomaterials (xenogenic and synthetic analogs), including the use of biological precursors of bone apatite mineralization having osteoinductive (stimulating) properties.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
17 Years 至 85 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient must have voluntarily signed the informed consent
  • Males and females, 18 years to 75 years of age
  • Patient needs single tooth extraction in mandibular or maxillary incisor or pre-molar region and would benefit from prosthetic reconstruction with a dental implant
  • Patients must be committed to the study and must sign informed consent
  • Patient in good general health as documented by self assessment

排除标准

  • Systemic exclusion criteria:
  • Patient who has any known diseases (not including controlled diabetes mellitus), infections or recent surgical procedures within 30 days of study initiation
  • Female patient who are pregnant or lactating or of child bearing potential not using acceptable methods of birth control (hormonal, barriers or abstinence
  • Patient who are on chronic treatment (i.e., two weeks or more) with any medication known to affect oral status (e.g., phenytoin, dihydropyridine calcium antagonists, cyclosporine, and non-steroidal anti-inflammatory drugs) within one month of baseline visit
  • Patient who knowingly has HIV or Hepatitis
  • Alcoholism or chronically drug abuse causing systemic compromisation
  • Patient who is a heavy smoker (>10/cigarettes per day).
  • Local exclusion criteria
  • Uncontrolled or untreated periodontal disease
  • Patient who has a full mouth plaque level >30 % at the enrolment visit
  • History of local radiation therapy
  • Presence of oral lesions (such as ulceration, malignancy)
  • Persistent intraoral infection
  • Patients presenting clinical and radiological signs and symptoms of maxillary sinus disease
  • Patient presents an acute endodontic lesion in the test tooth or in the neighbouring areas to the experimental procedure (sites with presence of an asymptomatic chronic lesion are eligible)

研究组 & 干预措施

Octacalcium phosphate

Experimental

Bone augmentation, after tooth extraction, with Octacalcium phosphate (synthetic bone graft material) in combination with resorbable collagen membrane Bio-Gide.

干预措施: Octacalcium phosphate (Device)

Bio-Oss

Active Comparator

Bone augmentation, after tooth extraction, with Bio-Oss (bovine-derived xenograft)in combination with resorbable collagen membrane Bio-Gide

干预措施: Bio-Oss (Device)

Tricalcium phosphate

Active Comparator

Bone augmentation, after tooth extraction, with Tricalcium phosphate (synthetic bone graft material) in combination with resorbable collagen membrane Bio-Gide.

干预措施: Tricalcium phosphate (Device)

结局指标

主要结局

The changes of bone level between baseline and 3 months post-extraction at the time of implantation

时间窗: baseline and 3 months post-extraction

A prefabricated stent will be used as an anchor point. After tooth extraction size of dehiscence of buccal bone from anchor point to the alveolar crest will be measured (baseline). Socket will be filled with biomaterial. After 3 months of healing at the time of implant placement the same stent will be used as an anchor point to measure size of dehiscence after socket preservation.

次要结局

  • Percent new vital bone formation(3 month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Alex Gurin

Teaching Assistant, PhD

I.M. Sechenov First Moscow State Medical University

研究点 (2)

Loading locations...

相似试验

Ridge Preservation With New Class of Osteoplastic... | 临床试验